Senate Finance Committee releases text of bill to lower drug prices

Senate Finance Committee leaders yesterday released the statutory text for the Prescription Drug Pricing Reduction Act of 2019 (S-2543), which closely mirrors the chairman’s mark that passed the committee in July.
Among other provisions, the bill would:
- Make a number of changes to the Medicare Part D program, including reducing beneficiary cost-sharing and tying drug price increases to the rate of inflation.
- Make more information on pharmacy benefit manager practices and manufacturer drug pricing publicly available.
- Change how Medicare calculates Part B prescription drug payment amounts to lower spending and beneficiary out-of-pocket costs; apply "site-neutral" payment cuts to drug administration services furnished in grandfathered off-campus provider-based departments; and cap at $1,000 the add-on payment for each Part B drug paid under the average sales price or wholesale acquisition cost methodology.
- Allow Medicaid to pay for gene therapies for rare disease through new risk-sharing value-based agreements; pressure manufacturers to lower list prices and report more accurate calculations of their rebate obligations; and prevent spread pricing by PBMs in the Medicaid program.
- Increase the Medicaid rebate cap from 100% to 125% of a drug's average manufacturing price, intended to discourage drug manufacturers' price increases in non-Medicaid markets; and allow states to apply Medicaid drug rebate requirements to drugs provided in outpatient hospital services through bundled or value-based payment arrangements.
Related News Articles
Headline
The AHA July 3 released the Health Care Plan Accountability Update for the second quarter of 2025. The update covers the latest developments in Medicare…
Headline
The Departments of Justice and Health and Human Services today announced the creation of the DOJ-HHS False Claims Act Working Group to combat health care fraud…
Headline
The Centers for Medicare & Medicaid Services today announced it has identified a fraud scheme targeting Medicare providers and suppliers. CMS said scammers…
Headline
A report released June 17 by NORC at the University of Chicago, commissioned by the Coalition to Strengthen America’s Healthcare, found that patients enrolled…
Headline
The Centers for Medicare and Medicaid Services May 30 released a notice requesting comments on a proposed Medicare Advantage service level data collection…
Headline
The AHA commented to the Centers for Medicare & Medicaid Services June 10 on the fiscal year 2026 inpatient prospective payment system proposed rule (https…